CG Oncology appoints Christina Rossi to board; director Simone Song resigns

CG Oncology, Inc.

Christina Rossi appointed to Board as Class II director effective November 24, 2025.
Rossi receives $45K annual retainer and initial option award of 20,889 shares vesting over 3 years.
Simone Song resigned from Board and all committees effective November 22, 2025; no disagreement cited.
Song served on Audit Committee and chaired Compensation Committee; no replacement committees named.
Standard indemnification agreement entered with Rossi; no transactions requiring disclosure.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.